On April 28 , 2026, United Community Banks, Inc. (the “Company”) and Jefferson L. Harralson (the “Executive”) entered into an Agreement dated as of April 28 , 2026 (the “Harralson Agreement”) pursuant to which Executive will resign, effective as of December 31, 2026 (the “Employment Termination Date”), as Executive Vice President and Chief Financial Officer of the Company.
the directors and officers of Purchaser as of immediately prior to the Effective Time, which consisted of Andrew D. Dickinson, Keeley Cain Wettan, and Thomas Kennedy, became the directors and officers of the Company.
the directors and officers of Purchaser as of immediately prior to the Effective Time, which consisted of Andrew D. Dickinson, Keeley Cain Wettan, and Thomas Kennedy, became the directors and officers of the Company.
On April 22, 2026, Rohit Goenka notified Morgan Stanley Investment Management Inc., the delegated sponsor of Morgan Stanley Bitcoin Trust (the “Delegated Sponsor”), of his intention to resign from his position as Chief Financial Officer of the Delegated Sponsor.
announced that John Townsend, Executive Vice President, Chief Financial Officer of the Company, has notified the Company that he is resigning effective April 30, 2026 to pursue another professional opportunity.
Appointed
Eric “Rick” Marmurek
Executive Vice President, Chief Financial Officer and Chief Accounting Officer
the Company announced that it is promoting Eric “Rick” Marmurek to the position of Executive Vice President, Chief Financial Officer and Chief Accounting Officer of the Company effective May 1, 2026.
Departed
Suketu Upadhyay
Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain
On April 22, 2026, Suketu Upadhyay informed Zimmer Biomet Holdings, Inc. (the “Company”) of his intention to resign from the position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain of the Company, effective as of April 28, 2026, to pursue a new professional opportunity.
Paul Stellato, Vice President, Controller and Chief Accounting Officer, has been appointed to act, along with continuing to serve in his current role, as the Company’s interim Chief Financial Officer, effective upon Mr. Upadhyay’s departure, until a permanent successor is named.
the Board of Directors (the “Board”) of the Company appointed Robert G. Lucian to serve as the Chief Financial Officer of the Company, effective the week of April 27, 2026
On April 28, 2026, Ultra Clean Holdings, Inc. (the “Company”) announced that Sheri Savage, the Company’s Chief Financial Officer, notified the Company of her intention to retire from the Company.
Effective April 27, 2026, Mr. Paul Taylor has assumed the positions of Chairman of the Board and Chief Executive Officer of Visium Technologies, Inc. (the “Company”).
On June 25, 2025, STAAR Surgical Company (the “Company”) announced that its Board of Directors (the “Board”) appointed Deborah Andrews as Chief Financial Officer of the Company, effective June 25, 2025 (the “Effective Date”).
On June 24, 2025, the Board of Directors (the “Board”) of Acacia Research Corporation (“Acacia” or the “Company”) appointed Michael Zambito as the Company’s Chief Financial Officer (“CFO”).
As previously disclosed, on May 28, 2025, Mr. Stauffer notified the Company of his decision to resign as the Company’s Chief Financial Officer, effective July 18, 2025.
As of the date hereof, Mr. Krysler is no longer Pure’s Chief Financial Officer, though he remains an employee of Pure and will provide ongoing services to help ensure a smooth transition of his duties and responsibilities.
Departed
Peter H. Nielsen
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Principal Accounting Officer, Chairman of the Board
On June 20, 2025, Peter H. Nielsen notified the Board of Directors (the “Board”) of Bio-Path Holdings, Inc. (the “Company”) of his decision to resign as President, Chief Executive Officer, Chief Financial Officer, Treasurer, Principal Accounting Officer, Chairman of the Board, member of the Board and all committees of the Board on which he served for the Company.
On June 18, 2025, the Board approved the appointment of Mr. O’Leary as President and Chief Executive Officer on a permanent, non-interim basis, effective July 1, 2025.
Role change
Joseph D. Fisher
Chief Financial Officer and principal financial officer
upon the effective date of Mr. Bragg’s appointment to serve as Senior Vice President - Chief Financial Officer and principal financial officer, Joseph D. Fisher will relinquish his roles and responsibilities as Chief Financial Officer and principal financial officer, and retain the roles of President and Chief Investment Officer of the Company.
The Board of Directors of UDR, Inc. (the “Company”) has approved the appointment of David D. Bragg to serve as the Company’s Senior Vice President - Chief Financial Officer, and as principal financial officer for the purposes of the Company’s filings with the Securities and Exchange Commission and for all other purposes contemplated thereby.
Appointed
Craig Albright
Executive Vice President and Chief Financial Officer
John Wiley & Sons, Inc. (the “Company”) issued a press release today, June 23, 2025, announcing the appointment of Craig Albright as Executive Vice President and Chief Financial Officer, reporting to President and Chief Executive Officer, Matthew S. Kissner, effective June 26, 2025.
Also on June 18, 2025, David Ruud, Executive Vice President and Chief Financial Officer was named Vice Chairman and Chief Financial Officer, effective September 8, 2025, at which time Mr. Ruud will receive an increase in base salary to $800,000.
On June 19, 2025, the Board of Directors of DTE Energy Company (the “Company” or “DTE Energy”) elected Joi M. Harris, DTE Energy’s President and Chief Operating Officer, as President and Chief Executive Officer, effective September 8, 2025.
In connection with this promotion and these appointments, Ms. Winn will resign from her current role as the chief executive officer of SDG&E but continue to serve as a director and be appointed as the non-executive chairman of the board of directors of SDG&E
the Board has appointed Mr. Jeffrey M. Ettinger as the Interim Chief Executive Officer of the Company (the 'Interim CEO') and Mr. John F. Ghingo as the President of the Company (the 'President'), in each case effective as of July 14, 2025.
James P. Snee, President and Chief Executive Officer ('CEO') of the Company will be retiring at the end of the Company's fiscal year 2025, which ends October 26, 2025.
Mark O. Decker, Jr, age 49, was appointed Chief Executive Officer and President of the Company, effective as of June 23, 2025.
Departed
Chad L. Stephens
President and Chief Executive Officer
PHX MINERALS INC.
Effective
2025-06-23
Successor
Daniel Herz
Filed
June 23, 2025, 7:59 PM ET
the employment of each of Ralph D’Amico, the Company’s Chief Financial Officer and Executive Vice President and Chad L. Stephens, the Company’s President and Chief Executive Officer was terminated at the effective time of the Merger.
Appointed
Daniel Herz
Chief Executive Officer
PHX MINERALS INC.
Effective
2025-06-23
Filed
June 23, 2025, 7:59 PM ET
Daniel Herz appointed as Chief Executive Officer of the Company, Jeff Smith appointed as President of the Company, and Jeffrey Slotterback appointed as Chief Financial Officer and Secretary of the Company.
Appointed
Jeffrey Slotterback
Chief Financial Officer and Secretary
PHX MINERALS INC.
Effective
2025-06-23
Filed
June 23, 2025, 7:59 PM ET
Daniel Herz appointed as Chief Executive Officer of the Company, Jeff Smith appointed as President of the Company, and Jeffrey Slotterback appointed as Chief Financial Officer and Secretary of the Company.
Departed
Ralph D'Amico
Chief Financial Officer and Executive Vice President
PHX MINERALS INC.
Effective
2025-06-23
Successor
Jeffrey Slotterback
Filed
June 23, 2025, 7:59 PM ET
the employment of each of Ralph D’Amico, the Company’s Chief Financial Officer and Executive Vice President and Chad L. Stephens, the Company’s President and Chief Executive Officer was terminated at the effective time of the Merger.
On June 20, 2025, Matthew Doctor, the President and Chief Executive Officer and a member of the Board of Directors (the “Board”) of Regis Corporation (the “Company”) notified the Board that he would resign his positions, effective June 30, 2025.
the Board appointed Jim Lain, the Company’s Executive Vice President, Brand Operations - Supercuts and Cost Cutters, to serve as Interim President and Chief Executive Officer, effective July 1, 2025
On June 20, 2025, the board of directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) unanimously appointed Charles Schoch as the Company’s Chief Financial Officer, effective June 20, 2025
appointed Mr. Jian Huang, a current member of the Board and the Company’s Executive Vice President, as Co-Chief Executive Officer of the Company, effective immediately.
On June 16, 2025, the Company received notices of resignation from Annie Pratt, resigning from her role as President of the Company and from the Board, and Sarah Wyant, resigning from her role as Chief Financial Officer of the Company, each effective as of June 16, 2025.
On June 13, 2025 , the Company’s Board of Directors appointed Kelly Brown, President of the Company’s Property Management Division, and Keith Schroeder, the Company’s current Chief Financial Officer and Secretary, to each act as interim Co-Chief Executive Officers effective as of July 1, 2025, and their focus will be on growing the Company’s Property Management Division and right sizing the Company and its subsidiaries.
On June 13, 2025 , the Company’s Board of Directors appointed Kelly Brown, President of the Company’s Property Management Division, and Keith Schroeder, the Company’s current Chief Financial Officer and Secretary, to each act as interim Co-Chief Executive Officers effective as of July 1, 2025, and their focus will be on growing the Company’s Property Management Division and right sizing the Company and its subsidiaries.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.